OBLN
Obalon Therapeutics, Inc.
Set alert
3.05 0.00 0.00%
2.95 Day range 4.80
52-week range unavailable
- Open
- 3.25
- Prev close
- 3.05
- Mkt cap
- 30.57M
- Vol
- 26.47M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.95
- High
- 4.80
- Forward P/E
- -11.30
- Beta
- -1.24
- Short ratio
- 0.08
- Inst. own
- 31.70%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jul 29, 2021
- 50-d avg
- 9.14
- 200-d avg
- 9.08
- 1y target
- 6.15
Financial health
Altman Z-Score
-14.83 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E 0.0×
FY 2014 5y median -0.4× FY 2025
P/S 0.0×
FY 2014 5y median 2.7× FY 2025
P/B 0.0×
FY 2014 5y median 0.6× FY 2025
P/FCF 0.0×
FY 2014 5y median -0.4× FY 2025
EV/EBITDA 0.5×
FY 2014 5y median 0.2× FY 2025
EV/Sales -15.5×
FY 2014 5y median 0.2× FY 2025
FCF Yield 0.0%
FY 2014 5y median -90.8% FY 2025
Profitability
Gross Margin 68.4%
FY 2014 5y median 40.4% FY 2025
Operating Margin -3237.8%
FY 2014 5y median -670.2% FY 2025
Net Margin -3277.2%
FY 2014 5y median -721.6% FY 2025
ROE -278.5%
FY 2014 5y median -264.4% FY 2025
ROIC -272.9%
FY 2014 5y median -160.1% FY 2025
ROA -161.3%
FY 2014 5y median -123.0% FY 2025
Growth (YoY)
Revenue -96.0%
FY 2014 FY 2025
Operating Income -55.2%
FY 2014 FY 2025
EPS (diluted) 100.0%
FY 2014 FY 2025
Free Cash Flow 100.0%
FY 2014 FY 2025
Financial Health
Current Ratio 2.0×
FY 2014 5y median 1.7× FY 2025
Quick Ratio 2.0×
FY 2014 5y median 1.6× FY 2025
Debt / Equity 0.0×
FY 2014 5y median 0.1× FY 2025
Net Debt / EBITDA 0.5×
FY 2014 5y median 0.5× FY 2025
Interest Coverage 70.6×
FY 2014 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2014 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2014 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31